Contact Us marketing@medicilon.com
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
SERVICES
SERVICES
01 Drug Discovery
Chemistry Research Biology Research Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings
PLATFORM
PLATFORM
01 One-stop Integrated Services
Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D
02 Innovative Drug R&D Services
Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model
05 High-end Preparations Technology Platform
Skin Topical Preparation Ophthalmic drug Inhalation drug
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service
07 Safety Assessment Lab of Process Chemistry

08 Public Services
CAREERS
Talent Development
Campus Recruitment
Recruitment
NEWS
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
INVESTORS
Stock Information
Investment Contact
CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
CN
×
中
Close Button
Medicilon Events
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsMedicilon Events

Medicilon Events

Hot information：
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model
May 05,2014
Medicilon successfully participated AACR Annual Meeting 2014 and CABA Annual Meeting at Boston
In early April，Medicilon's VP of Biology, Dr. Jun Wang and BD Directors attended the AACR.  During the five-day conference, many attendees and researchers showed strong
More
Medicilon successfully participated AACR Annual Meeting 2014 and CABA Annual Meeting at Boston
Apr 28,2014
Medicilon were invited to attend the 1st Annual Xiamen Bio Bay Biotech Summit
The 1st Annual Xiamen Bio-Pharmaceutical Companies Salon was held in Xiamen Bio Bay on April 25.  The purpose of the salon was to help the
More
Medicilon were invited to attend the 1st Annual Xiamen Bio Bay Biotech Summit
Apr 25,2014
CEO of Medicilon, was invited to attend " 1st Bio-Pharmaceutical Enterprises Salon in Xiamen"
On April 25, HangCang Biological Medicine Association will organized  the " 1st Bio-Pharmaceutical Enterprises Salon in Xiamen" .  CEO of Medicilon, was invited.
More
CEO of Medicilon, was invited to attend " 1st Bio-Pharmaceutical Enterprises Salon in Xiamen"
Apr 18,2014
HQL, Longthera and Medicilon Form Collaboration to Co-Develop Novel anti-cancer drug targeting
04/18/2014, Longthera Pharmaceuticals, a pre-clinical stage biopharmaceutical company, based in Jiangsu Province, China, and HQL Pharmaceuticals, a drug discovery company utilizing its super power ChemSpace
More
HQL, Longthera and Medicilon Form Collaboration to Co-Develop Novel anti-cancer drug targeting
Apr 03,2014
Medicilon was awarded to establish a Shanghai Academicians and Experts Workstation
In order to implement the new policy of China Association for Science and Technology (CAST), accelerate high-level research cooperation and support the innovation of academicians,
More
Medicilon was awarded to establish a Shanghai Academicians and Experts Workstation
Mar 17,2014
Medicilon passed CFDA review and examination
Medicilon provides different models for pharmacology services such as Cancer Xenograft Models, Neurological Disorders Models, Inflammation & Immunological Disease Models and Metabolic Disease Models.  Medicilon
More
Medicilon passed CFDA review and examination
Mar 03,2014
Medicilon hosted a Preclinical Development of Innovative Drugs Summit
Followed by 3 Chinese New Year & 10th Anniversary Gala Dinners hosted in USA, Medicilon hosted the fourth anniversary gala dinner along with the pre-clinical
More
Medicilon hosted a Preclinical Development of Innovative Drugs Summit
Feb 14,2014
Medicilon was mentioned by Nature Journal
On Jan 29, Medicilon was mentioned by an article which was published on Nature.com – a prominent interdisciplinary scientific journal, with the topics, "Structural biology:
More
Medicilon was mentioned by Nature Journal
Dec 14,2013
Medicion held a 2013 GLP Meeting
On Dec 13, all the VPs who responsible for drug safety evaluation from Shanghai gathered together at Pudong to attend the annual GLP meeting held
More
Medicion held a 2013 GLP Meeting
Dec 13,2013
Medicilon was named "2013 China's Top Ten Most Valuable CRO Enterprises”
In order to encourage the creativity of pharmaceutical industry enterprises, accelerate the transformation of high-tech achievements into productive pace, enhance the market competitiveness and promote
More
Medicilon was named "2013 China's Top Ten Most Valuable CRO Enterprises”
Nov 29,2013
LegoChem, Longthera and Medicilon Form Collaboration to Co-develop New Antibiotic LCB01-0699
SHANGHAI, November 27, 2013 –LegoChem and Longthera today announced that they have entered into a collaboration agreement to co-develop LegoChem's LCB01-0699, a novel antibiotic small
More
LegoChem, Longthera and Medicilon Form Collaboration to Co-develop New Antibiotic LCB01-0699
Nov 19,2013
Medicilon attended the 6th National Congress of Toxicology successfully in Guangzhou
The 6th National Congress of Toxicology is the Chinese highest level academic conference of toxicology.  Medicilon is one of the best CRO which provides toxicology
More
Medicilon attended the 6th National Congress of Toxicology successfully in Guangzhou
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->